Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabinerefractory pancreatic cancer patients

By                                  

Oncology Letters, Vol. 3, Iss. 6, 2012-01 ,pp. : 1314-1318

Spandidos Publications

Access to resources Recommend Favorite

Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

By Kusaba Hitoshi   Esaki Taito   Kishimoto Junji   Uchino Keita   Arita Shuji   Kumagai Hozumi   Mitsugi Kenji   Akashi Koichi   Baba Eishi  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 29-34

Springer Publishing Company

Access to resources Recommend Favorite

Second-line chemotherapy in patients with primary unknown cancer

By Ono Makiko   Ando Masashi   Yonemori Kan   Yamamoto Harukaze   Hirata Taizo   Shimizu Chikako   Tamura Kenji   Katsumata Noriyuki   Fujiwara Yasuhiro  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1185-1191

Springer Publishing Company

Access to resources Recommend Favorite

The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer

By Boeck Stefan   Heinemann Volker  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 41-50

Future Medicine

Access to resources Recommend Favorite

The Effectiveness of S-1 Based Sequential Chemotherapy as Second-Line Treatment for Advanced/Recurrent Gastric Cancer

By Sugimoto Naotoshi   Narahara Hiroyuki   Sakai Daisuke   Yamamoto Sachiko   Fumoto Shoichi   Yagi Toshinari   Imamura Fumio   Iishi Hiroyasu   Tatsuta Masaharu  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 417-424

Sunmedia

Access to resources Recommend Favorite